Incubate submits comment to CMS regarding its draft guidance for the Medicare Drug Price Negotiation Program

Incubate submitted our feedback to the Centers for Medicare & Medicaid Services regarding its draft guidance for the Medicare Drug Price Negotiation Program.

---

04.17.2023

Recently, Incubate submitted our feedback to the Centers for Medicare & Medicaid Services regarding its draft guidance for the Medicare Drug Price Negotiation Program – the agency’s roadmap for how it will implement the IRA’s drug pricing provisions.

View our full comment below.